The burden of unscheduled health care for asthma in Latin America

Journal of Investigational Allergology and Clinical Immunology

Volumn 20, Issue 7, 2010, Pages 596-601

  Neffen, H ^a   Gonzalez, S N ^b   Fritscher, C C ^c   Dovali, C ^d   Williams, A E ^e  

^a 'O Alassia' Children's Hospital   (Argentina)

^b HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d Estrada dos Bandeirantes   (Brazil)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Asthma prevention and control; Cost; Latin America

Indexed keywords

ADOLESCENT; ADULT; ARGENTINA; ARTICLE; ASTHMA; BRAZIL; CHILD; CHILE; COLOMBIA; CONTROLLED STUDY; COSTA RICA; DISEASE CONTROL; DISEASE SEVERITY; ECUADOR; EMERGENCY HEALTH SERVICE; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MEXICO; MILD INTERMITTENT ASTHMA; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; PERU; SEVERE PERSISTENT ASTHMA; SOUTH AND CENTRAL AMERICA; URUGUAY; VENEZUELA;

ADOLESCENT; ADULT; ASTHMA; DELIVERY OF HEALTH CARE; FEMALE; HEALTH CARE COSTS; HUMANS; LATIN AMERICA; MALE; YOUNG ADULT;

EID: 79251468777     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Updated 2005. Available from www. ginasthma.org.
2. Braman SS. The global burden of asthma. Chest. 2006;130(1 Suppl):4S-12S.
3. Carrasco E. Epidemiologic aspects of asthma in Latin America. Chest. 1987;91(6 Suppl):93S-97S.
4. Fischer GB, Camargos PA, Mocelin HT. The burden of asthma in children: a Latin American perspective. Paediatr Respir Rev. 2005;6(1):8-13.
5. Asher M I, Montefort S, Björksten B, Lai CK, Strachan DP, Weiland SK, Williams H; ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergy rhinoconjunctivitis and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. The Lancet. 2006;368:733-43.
6. Shanawani H. Health disparities and differences in asthma: concepts and controversies. Clin Chest Med. 2006;27(1):17-28.
7. Vergara C, Caraballo L. Asthma mortality in Columbia. Ann Allergy Asthma Immunol. 1998;80(1):55-60.
8. Santo AH. Asthma-related mortality, Brazil, 2000: a study using multiple causes of death. Cad Saude Publica. 2006;22(1):41-52.
9. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16:802-7.
10. Adams RJ, Fuhlbrigge A, Guilbert T, Lozano P, Martinez F. Inadequate use of asthma medication in the United States: results of the Asthma in America national population survey. J Allergy Clin Immunol. 2002;110:58-64.
11. Lai CWK, de Guia TS, Kim Y-Y, Kuo S-H, Mukhopadhyay A, Soriano JB Trung PL, Zhong NS, Zainudin N, Zainudin BM; Asthma Insights and Reality in Asia-Pacific Steering Committee. Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol. 2003;111:263-8.
12. Neffen H, Fritscher C, Cuevas Schacht F, Levy G, Chiarella P, Soriano JB Mechali D; AIRLA Survey Group. Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey. Rev Panam Salud Publica/Pan Am J Public Health. 2005;17(3):19-7.
13. Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respir Med. 2006 Jul;100(7):1139-51
14. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996; 9(4): 636-42.
15. Antonicelli L, Bucca C, Neri M, De Benedetto F, Sabbatani P, Bonifazi F Eichler HG, Zhang Q, Yin DD. Asthma severity and medical resource utilization. Eur Respir J 2004; 23(5): 723-9.
16. Barnes NC, Williams AE. Unscheduled healthcare resource use among asthma patients receiving low-dose inhaled corticosteroids maintenance treatment. Int J Clin Pract. 2005;59(9):1017-24.
17. Sullivan SD. The burden of uncontrolled asthma on the US health care system. Manag Care. 2005;14(8 Suppl):4-7.
18. Accordini S, Bugiani M, Arossa W, Gerzeli S, Marinoni A, Olivieri M Pirina P, Carrozzi L, Dallari R, De Togni A, de Marco R. Poor control increases the economic cost of asthma. A multicentre populationbased study. Int Arch Allergy Immunol. 2006;141(2):189-198.
19. Williams AE, Lloyd AC, Watson L, Rabe KF. The cost of scheduled and unscheduled healthcare resource use for asthma management in seven EU countries. Proc Am Thorac Soc. 2005;2(Abs):A926.
20. Lara M, Duan N, Sherbourne C, Lewis MA, Landon C, Halfon N, Brook RH. Differences between child and parent reports of symptoms among latino children with asthma. Pediatrics 1998;102(6):e68.
21. Lee TA, Weiss KB. An update on the health economics of asthma and allergy. Curr Opin Allergy Clin Immunol 2002;2:195-200.
22. Fritscher CC, Solé D, Rosário N. III Consenso Brasileiro no Manejo da Asma. J Pneumol. 2002; 28(Suppl 1): S4-S28.
23. Sociedad Mexicana de Neumología y Cirugía de Tórax. "Consenso Mexicano de Asma" Neumol Cir Torax. 2005; 64 (Suppl 1), 1405-2938. S13-S17.
24. Cooper PJ, Rodrigues LC, Cruz AA, Barreto ML. Asthma in Latin America: a public health challenge and research opportunity. Allergy. 2009; 64: 5-17.
25. Ponte E, Franco RA, Souza-Machado A, Souza-Machado C, Cruz AA. Impact that a program to control severe asthma has on the use of Unifi ed Health System resources in Brazil. J Bras Pneumol. 2007; 33:15-19.
26. Rodrigo GJ, Plaza V, Bellido-Casado J, Neffen H, Bazús MT, Levy G, Armengo J. The study of severe asthma in Latin America and Spain (1994-2004): characteristics of patients hospitalized with acute severe asthma. J Bras Pneumol. 2009; 35 (7): 635-644.
27. Neffen H, Baena-Cagnani C, Passalacqua G, Canonica GW, Rocco D. Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990-1999). Respiratory Medicine. (2006) 100, 1431-1435
28. Petrou S, Murray L, Cooper P, Davidson LL. The accuracy of selfreported healthcare resource utilization in health economic studies. Int J Technol Assess Health Care. 2002; 18(3):705-710.
29. Evans C, Crawford B. Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity. Pharmacoeconomics 1999; 15(3):241-256.